Physician
Otuechere, Valentine
Otuechere, Valentine was paid $907K by Medicaid between Jan 2018 and Sep 2024, across 85 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoOTUECHERE, VALENTINE
RIVERSIDE, CA 92503
RIVERSIDE, CA 92503
33aNPI1508896275assigned 07/05/2006
33bProvider typeInternal Medicine Physician
28Total paid$907K
24GClaims67,657
24DCodes billed85
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#153 of 2,679
Median peer was paid$13K
This provider vs. median72×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,453 | $314K | |
| 2019 | 9,906 | $147K | |
| 2020 | 6,698 | $56K | |
| 2021 | 6,728 | $136K | |
| 2022 | 10,328 | $90K | |
| 2023 | 10,253 | $103K | |
| 2024incomplete | 7,291 | $62K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 13,401 | 11,978 | $450K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 36% | 1,175 | 1,088 | $323K |
| 97802 | 2.2% | 4,424 | 4,405 | $20K | |
| 96156 | 2.0% | 2,011 | 2,010 | $18K | |
| 92551 | 1.8% | 2,946 | 2,932 | $17K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.5% | 1,997 | 1,990 | $14K |
| 90686 | 1.3% | 973 | 966 | $12K | |
| 99384 | <1% | 62 | 48 | $8K | |
| 99383 | <1% | 64 | 49 | $7K | |
| 99000 | <1% | 1,833 | 1,829 | $7K | |
| 88141 | <1% | 94 | 48 | $5K | |
| 90682 | <1% | 110 | 99 | $4K |
73 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,195 | $2K |
| G9920 | Screening performed and negative | <1% | 2,706 | $2K |
| 90688 | <1% | 154 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 450 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,767 | $1K |
| 90620 | <1% | 108 | $1K | |
| 81002 | <1% | 4,127 | $1K | |
| 85018 | <1% | 3,339 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,163 | $1K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 5,041 | $1K |
| 90715 | <1% | 115 | $993.30 | |
| 90734 | <1% | 162 | $888.44 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 253 | $808.63 |
| 99402 | <1% | 12 | $683.16 | |
| 99442 | <1% | 401 | $609.12 | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 226 | $575.00 |
| 90658 | <1% | 41 | $443.34 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 165 | $299.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 121 | $297.42 |
| 99406 | <1% | 649 | $297.16 | |
| 90649 | <1% | 166 | $276.18 | |
| 1158F | <1% | 2,072 | $275.00 | |
| 81025 | <1% | 83 | $232.37 | |
| 90633 | <1% | 19 | $171.00 | |
| 86580 | <1% | 15 | $164.37 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 2,321 | $158.55 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 622 | $149.00 |
| 83655 | <1% | 17 | $142.97 | |
| 99188 | <1% | 27 | $125.00 | |
| 90744 | <1% | 12 | $108.00 | |
| H0049 | Alcohol and/or drug screening | <1% | 1,433 | $100.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 351 | $96.20 |
| 3078F | <1% | 324 | $50.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 53 | $25.20 |
| 3074F | <1% | 156 | $25.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 28 | $17.04 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 32 | $12.96 |
| 80061 | Lipid panel | 0% | 438 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 280 | $0.00 |
| 3077F | 0% | 54 | $0.00 | |
| 86696 | 0% | 187 | $0.00 | |
| 99173 | 0% | 13 | $0.00 | |
| 81003 | 0% | 351 | $0.00 | |
| 82274 | 0% | 15 | $0.00 | |
| 1159F | 0% | 21 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 30 | $0.00 |
| 1160F | 0% | 21 | $0.00 | |
| 85610 | 0% | 16 | $0.00 | |
| 99397 | 0% | 19 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 530 | $0.00 |
| 0545F | 0% | 394 | $0.00 | |
| 99385 | 0% | 161 | $0.00 | |
| 3061F | 0% | 148 | $0.00 | |
| 86592 | 0% | 314 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 405 | $0.00 |
| 86695 | 0% | 185 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 539 | $0.00 |
| 82043 | 0% | 107 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 279 | $0.00 |
| H0001 | Alcohol and/or drug assessment | 0% | 1,233 | $0.00 |
| 87081 | 0% | 85 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 12 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 472 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 429 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 153 | $0.00 |
| 1031F | 0% | 43 | $0.00 | |
| 99386 | 0% | 25 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 310 | $0.00 |
| 3351F | 0% | 295 | $0.00 | |
| 3044F | 0% | 31 | $0.00 | |
| 84153 | 0% | 13 | $0.00 | |
| 3075F | 0% | 12 | $0.00 | |
| 1170F | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.